Mercer Global Advisors’s Dr. Reddy's Laboratories RDY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $378K | Sell |
25,171
-637
| -2% | -$9.57K | ﹤0.01% | 1687 |
|
|
2025
Q1 | $340K | Sell |
25,808
-1,611
| -6% | -$21.2K | ﹤0.01% | 1691 |
|
|
2024
Q4 | $433K | Sell |
27,419
-105,521
| -79% | -$1.67M | ﹤0.01% | 1528 |
|
|
2024
Q3 | $424K | Buy |
132,940
+108,215
| +438% | +$345K | ﹤0.01% | 1426 |
|
|
2024
Q2 | $377K | Buy |
24,725
+1,580
| +7% | +$24.1K | ﹤0.01% | 1461 |
|
|
2024
Q1 | $335K | Sell |
23,145
-5,770
| -20% | -$83.5K | ﹤0.01% | 1502 |
|
|
2023
Q4 | $402K | Buy |
28,915
+11,585
| +67% | +$161K | ﹤0.01% | 1451 |
|
|
2023
Q3 | $232K | Sell |
17,330
-445
| -3% | -$5.96K | ﹤0.01% | 1688 |
|
|
2023
Q2 | $224K | Buy |
+17,775
| New | +$224K | ﹤0.01% | 1677 |
|
|
2022
Q3 | – | Sell |
-18,835
| Closed | -$209K | – | 1897 |
|
|
2022
Q2 | $209K | Sell |
18,835
-1,500
| -7% | -$16.6K | ﹤0.01% | 1618 |
|
|
2022
Q1 | $227K | Sell |
20,335
-2,420
| -11% | -$27K | ﹤0.01% | 1656 |
|
|
2021
Q4 | $298K | Sell |
22,755
-1,240
| -5% | -$16.2K | ﹤0.01% | 1467 |
|
|
2021
Q3 | $313K | Sell |
23,995
-5,160
| -18% | -$67.3K | ﹤0.01% | 1409 |
|
|
2021
Q2 | $429K | Buy |
29,155
+3,050
| +12% | +$44.9K | ﹤0.01% | 1213 |
|
|
2021
Q1 | $321K | Buy |
26,105
+2,780
| +12% | +$34.2K | ﹤0.01% | 1278 |
|
|
2020
Q4 | $333K | Buy |
23,325
+5,545
| +31% | +$79.2K | ﹤0.01% | 1032 |
|
|
2020
Q3 | $247K | Buy |
+17,780
| New | +$247K | ﹤0.01% | 1037 |
|